Atlas Trials

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Clinical trial NCT00436618 · COMPLETED

Trial details

NCT number
NCT00436618
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaLymphoproliferative Disorder
Start date
2005-08-01
Primary completion
2010-12-01
Enrollment
277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.